Literature DB >> 6895258

In vitro biotransformation of pyrazinamide by rat liver: identification of a new metabolite.

D Pitrè, R M Facino, M Carini, A Carlo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6895258     DOI： 10.1016/s0031-6989(81)80005-7

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN： 0031-6989


× No keyword cloud information.
  5 in total

1.  Haemodialysis of pyrazinamide in uraemic patients.

Authors:  C Lacroix; A Hermelin; R Guiberteau; C Guyonnaud; J Nouveau; H Duwoos; O Lafont
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects.

Authors:  C Lacroix; T P Hoang; J Nouveau; C Guyonnaud; G Laine; H Duwoos; O Lafont
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

4.  Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats.

Authors:  Xin Liu; Manman Zhao; Jiaqi Mi; Hui Chen; Li Sheng; Yan Li
Journal:  Molecules       Date:  2017-04-07       Impact factor: 4.411

5.  An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage.

Authors:  Zhang-He Goh; Jie Kai Tee; Han Kiat Ho
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.